FDA - Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring Facilities

25th October 2023

Today, FDA issued a draft guidance to inform industry about the agency’s continued use of remote interactive evaluations as an approach for evaluating drug facilities, as appropriate.

Take a look at the guidance here.

Back to News Archive